Segment Information - Summary of Financial Information for the Company's Segments (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Segment Reporting Information
Consolidated revenue	$ 104,406	$ 94,666
Total segment depreciation expense	1,011	715
Total segment amortization	773	774
Selling, general and administrative expense	25,376	28,452
Non-segment depreciation and amortization	1,784	1,489
Total consolidated operating loss	(9,911)	(17,972)
Interest expense, net	5,570	1,985
Change in fair value of derivative warrant liabilities	43	0
Change in fair value of conversion option derivative liabilities	3,309	0
Other, net	752	(68)
Consolidated loss before provision for income taxes	(19,585)	(19,889)
Operating segments
Segment Reporting Information
Consolidated revenue	104,406	94,666
Total segment direct costs	87,157	82,697
Total segment depreciation expense	789	546
Total segment amortization	773	773
Total segment operating income	15,687	10,650
Selling, general and administrative expense	25,376	28,452
Operating segments | Intravenous (IV) drug costs
Segment Reporting Information
Total segment direct costs	31,413	32,724
Operating segments | Clinician salaries and benefits
Segment Reporting Information
Total segment direct costs	14,074	15,461
Operating segments | Medical supplies and other
Segment Reporting Information
Total segment direct costs	1,593	1,312
Non-segment assets
Segment Reporting Information
Non-segment depreciation and amortization	222	170
Patient services | Operating segments
Segment Reporting Information
Consolidated revenue	53,068	52,453
Total segment direct costs	47,080	49,497
Total segment depreciation expense	755	515
Total segment amortization	718	718
Total segment operating income	4,515	1,723
Dispensary | Operating segments
Segment Reporting Information
Consolidated revenue	49,293	39,679
Total segment direct costs	39,863	32,809
Total segment depreciation expense	32	31
Total segment operating income	9,398	6,839
Clinical trials & other | Operating segments
Segment Reporting Information
Consolidated revenue	2,045	2,534
Total segment direct costs	214	391
Total segment depreciation expense	2	0
Total segment amortization	55	55
Total segment operating income	$ 1,774	$ 2,088